Radionuclide imaging for the assessment of esophageal motility disorders in mixed connective tissue disease patients: Relation to pulmonary impairment

Diseases of the Esophagus

Volumn 19, Issue 5, 2006, Pages 394-400

  Caleiro, M T C ^a   Lage, L V ^a   Navarro Rodriguez, T ^a   Bresser, A ^a   da Costa, P A ^a   Yoshinari, N H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Esophageal motility disorders; Gastroesophageal reflux; Interstitiallung disease; Mixedconnective tissue disease; Radionuclide imaging

Indexed keywords

TECHNETIUM 99M;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DISEASE ASSOCIATION; ESOPHAGITIS; ESOPHAGOGRAPHY; ESOPHAGUS BIOPSY; ESOPHAGUS FUNCTION; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MOTILITY; ESOPHAGUS MUCOSA; ESOPHAGUS SCINTISCANNING; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; LUNG DISEASE; LUNG VOLUME; MALE; MEAL; MIXED CONNECTIVE TISSUE DISEASE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RADIATION EXPOSURE; STANDARDIZATION; STATISTICAL ANALYSIS;

ADULT; CASE-CONTROL STUDIES; DEGLUTITION DISORDERS; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGITIS; FEMALE; GASTRITIS; HEARTBURN; HERNIA, HIATAL; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MUCOCILIARY CLEARANCE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS;

EID: 33748705371     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00598.x     Document Type: Article

References (37)

1. Fizgerald R C, Triadafilopoulos G. Esophageal manifestations of Rheumatic diseases. Sem Arthr Rheum 1997; 26: 641-66.
2. Revicki D A, Wood M, Maton P N, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998; 104: 252-8.
3. Del Rosario J F, Oresntein S R. Evaluation and management of gastroesophageal reflux and pulmonary disease. Curr Opin Pediatr 1996; 8: 209-15.
4. Tobin R W, Pope Ii C E, Pellegrini C A, Emond M J, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 1804-8.
5. Marshall J B, Kretschmar J M, Gerhardt D C et al. Gastrointestinal manifestations of MCTD. Gastroenterology 1990; 98: 1232-8.
6. Prakash U B. Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998; 19: 733-46.
7. Kasukawa R, Tojo T, Miyawaki S et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa, R, Sharp, GC, eds. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. Amsterdam: Elsevier 1987, 41-7.
8. Austin J H, Muller N L, Friedman P J et al. Glossary of terms for CT of the lungs: Recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996; 200: 327-31.
9. Drane W E, Karvelis K, Johnson D A, Curran J J, Silverman E D. Progressive systemic sclerosis: Radionuclide esophageal scintigraphy and manometry. Radiology 1986; 160: 73-6.
10. Tolin R D, Malmud L S, Reilley J, Fisher R S. Esophageal scintigraphy to quantitate esophageal transit (quantitation of esophageal transit). Gastroenterology 1979; 76: 1402-8.
11. Ismail-Beigi F, Horton P F, Pope C E. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58: 163-74.
12. Savary M, Miller G. The Esophagus. Handbook and Atlas of Endoscopy. Switzerland: Gassmann AG 1978, 135-9.
13. Flick J A, Boyle J T, Tuchman D N, Athreya B H, Doughty R A. Esophageal motor abnormalities in children and adolescents with scleroderma and mixed connective tissue disease. Pediatrics 1988; 82: 107-11.
14. Dimenas E. Methodological aspects of quality of life in upper gastrointestinal disease. Scand J Gastroenterol 1993; Suppl 199: 18-21.
15. Dent J, Jones R, Kahrilas P, Talley N J. Management of gastro-oesophageal reflux disease in general practice. BMJ 2001; 322: 344-7.
16. Dantas R O, Villanova M G, Godoy R A. Esophageal dysfunction in patients with progressive systemic sclerosis and mixed connective tissue diseases. Arq Gastroenterol (S Paulo) 1985; 22: 122-6.
17. Sjogren R W. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994; 37: 1265-82.
18. Kasukawa R. Mixed connective tissue disease. Int Med 1999; 38: 386-93.
19. Ling T C, Johnston B T. Esophageal investigations in connective tissue disease. Which tests are most apropriate? J Clin Gastroenterol 2001; 32: 33-6.
20. Clements P J, Kadell B, Ippoliti A, Ross M. Esophageal motility in progressive systemic sclerosis (PSS): Comparison of cineradiographic and manometric evaluation. Dig Dis Sci 1979; 24: 639-44.
21. De Merieux P, Verity M A, Clements R J, Paulus H E. Esophageal abnormalities and dysphagia in PM and DM: Clinical, radiographic, and pathological features. Arthritis Rheum 1983; 26: 961-8.
22. Kaye M D, Wexler R M. Alteration of esophageal peristalsis by body position. Dig Dis Sci 1981; 26: 897-901.
23. Wang S-J, Lan J L, Chen D Y, Chen Y H, Hsieh T Y, Lin W Y. Solid phase radionuclide esophageal transit in mixed connective tissue disease. Abdom Imaging 2002; 27: 6-8.
24. Kazem I. A new scintigraphic technique for the study of esophagus. Am J Roent Rad Ther Nucl Med 1972; 115: 681-8.
25. Carvalho M E P, Kairalla R A, Capelozzi V L, Deheinzelin D, Saldiva P H N, Carvalho C R R. Centrilobular fibrosis: A novel histological pattern of idiopathic interstitial pneumonia. Pathol Res Pract 2002; 198: 577-83.
26. Koufman J A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101 (4 Pt 2 Suppl 53): 1-78.
27. Fiss E, Motti C B, Chinzon D et al. Asthma induced by instillation of chloride acid in the esophagus. Chest 1994; 106: 147S.
28. Ing A J, Ngu M C. Cough and gastro-oesophageal reflux. Lancet 1999; 353: 944-6.
29. Fouad Y M, Katz P O, Hatlebakk J G, Castell D O. Ineffective esophageal motility: The most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroent 1999; 94: 1464-7.
30. Lamblin C, Bergoin C, Saelens T, Wallaert B. Interstitial lung disease in collagen vascular diseases. Eur Respir J 2001; 18: 69s-80s.
31. Sharp G C. MCTD: A concept which stood the test of time. Lupus 2002; 11: 333-9.
32. Girod C E, Schwarz M I. The lung in mixed connective tissue disease. Semin Respir Crit Care Med 1999; 20: 99-108.
33. Bodolay E, Szekanecz Z, Dévényi K et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology 2005; 44: 656-61.
34. Saito Y, Tereda M, Takada T et al. Pulmonary involvement in mixed connective tissue disease: Comparison with other collagen vascular diseases using High resolution CT. J Comput Assist Tomogr 2002; 26: 349-57.
35. Kozuka T, Johkoh T, Honda O et al. Pulmonary involvement in mixed connective tissue disease. High-resolution CT findings in 41 patients. J Thorac Imag 2001; 16: 94-8.
36. Sullivan W D, Hurst D J, Harmon C E et al. A prospective evaluation emphasizing pulmonary involvement in patients with MCTD. Medicine 1984; 63: 92-107.
37. Burdt M A, Hoffman R W, Deutscher S L, Wang G S, Johson J C, Sharp G C. Long-term outcome in mixed connective tissue disease. Longitudinal clinical and serologic findings. Arthritis Rheum 1999; 42: 899-909.